Treatment strategies for Von Hippel-Lindau syndrome

Ramaprasad Srinivasan, MD, PhD, National Cancer Institute, Bethesda, MD, discusses how to manage treatment for patients with Von Hippel-Lindau syndrome, and explains how treatment strategies have evolved over the years. Dr Srinivasan also highlights the surgical considerations for treating tumors in the kidney. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.